IN2014KN01211A - - Google Patents

Info

Publication number
IN2014KN01211A
IN2014KN01211A IN1211KON2014A IN2014KN01211A IN 2014KN01211 A IN2014KN01211 A IN 2014KN01211A IN 1211KON2014 A IN1211KON2014 A IN 1211KON2014A IN 2014KN01211 A IN2014KN01211 A IN 2014KN01211A
Authority
IN
India
Prior art keywords
nalmefene
hydrochloride
methylenemorphinan
cyclopropylmethyl
recovery
Prior art date
Application number
Other languages
English (en)
Inventor
Faveri Carla De
Mariano Stivanello
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48573602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014KN01211(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IN2014KN01211A publication Critical patent/IN2014KN01211A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1211KON2014 2011-12-06 2012-12-06 IN2014KN01211A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161567148P 2011-12-06 2011-12-06
DKPA201100948 2011-12-06
PCT/EP2012/074623 WO2013083685A1 (en) 2011-12-06 2012-12-06 Process for recovery of nalmefene hydrochloride

Publications (1)

Publication Number Publication Date
IN2014KN01211A true IN2014KN01211A (enExample) 2015-10-16

Family

ID=48573602

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1211KON2014 IN2014KN01211A (enExample) 2011-12-06 2012-12-06

Country Status (32)

Country Link
US (1) US8841452B1 (enExample)
EP (1) EP2788357B1 (enExample)
JP (1) JP6086925B2 (enExample)
KR (1) KR20140103288A (enExample)
CN (1) CN104093721B (enExample)
AR (1) AR089080A1 (enExample)
AU (1) AU2012347261B2 (enExample)
BR (1) BR112014013541B1 (enExample)
CA (1) CA2857096C (enExample)
CL (1) CL2014001454A1 (enExample)
CO (1) CO6970605A2 (enExample)
CY (1) CY1118785T1 (enExample)
DK (1) DK2788357T3 (enExample)
ES (1) ES2622156T3 (enExample)
HR (1) HRP20170497T1 (enExample)
HU (1) HUE033717T2 (enExample)
IL (1) IL232826A (enExample)
IN (1) IN2014KN01211A (enExample)
JO (1) JO3251B1 (enExample)
LT (1) LT2788357T (enExample)
ME (1) ME02668B (enExample)
MX (1) MX354331B (enExample)
PL (1) PL2788357T3 (enExample)
PT (1) PT2788357T (enExample)
RS (1) RS55817B1 (enExample)
RU (1) RU2631652C2 (enExample)
SG (1) SG11201402956UA (enExample)
SI (1) SI2788357T1 (enExample)
SM (1) SMT201700200T1 (enExample)
TW (1) TWI560170B (enExample)
WO (1) WO2013083685A1 (enExample)
ZA (1) ZA201404100B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105646508B (zh) * 2016-02-17 2018-02-27 南京卓康医药科技有限公司 一种盐酸纳美芬一水合物的制备方法
US10927121B1 (en) 2019-12-20 2021-02-23 Southwest Research Institute Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate
WO2022165040A1 (en) 2021-01-28 2022-08-04 Rhodes Technologies Process for crystallizing nalmefene hydrochloride
CN117986261B (zh) * 2024-04-02 2024-06-18 成都瑞尔医药科技有限公司 一种盐酸纳美芬母液的回收套用方法
CN119080788A (zh) * 2024-08-19 2024-12-06 南京海鲸药业股份有限公司 一种盐酸纳美芬杂质的去除监控系统及去除方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2577947A (en) * 1951-12-11 Manufacture of dihydrocodeinone
US3896226A (en) 1971-11-26 1975-07-22 Lewinstein Evalina 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts thereof, and use of the same as a narcotic antagonist
US3814768A (en) * 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
EP2003134B1 (en) * 1999-11-09 2011-03-02 Abbott Laboratories Hydromorphinone compositions
AU2003220290B2 (en) * 2002-03-14 2007-06-14 Euro-Celtique S.A. Naltrexone hydrochloride compositions
JP5695296B2 (ja) * 2006-03-02 2015-04-01 マリンクロッド エルエルシー 低レベルのアルファ,ベータ−不飽和ケトン化合物を伴うモルフィナン−6−オン生成物の製造方法
CN101652370A (zh) * 2006-12-04 2010-02-17 诺拉姆科有限公司 制备14-羟基可待因酮水平减少的羟考酮的方法
EP2121669A2 (en) 2007-01-30 2009-11-25 Biogen Idec MA, Inc. Furanone compounds and methods of making and using the same
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
EA019331B1 (ru) * 2009-05-25 2014-02-28 Х. Лундбекк А/С Получение налмефена гидрохлорида из налтрексона
CN101768164B (zh) * 2010-01-25 2011-09-14 海南数尔药物研究有限公司 一种高纯度的盐酸纳洛酮化合物

Also Published As

Publication number Publication date
PL2788357T3 (pl) 2017-07-31
AR089080A1 (es) 2014-07-30
RS55817B1 (sr) 2017-08-31
US20140296525A1 (en) 2014-10-02
LT2788357T (lt) 2017-04-25
CO6970605A2 (es) 2014-06-13
ZA201404100B (en) 2015-11-25
IL232826A (en) 2016-10-31
WO2013083685A1 (en) 2013-06-13
HRP20170497T1 (hr) 2017-06-02
EP2788357A1 (en) 2014-10-15
JP2015504856A (ja) 2015-02-16
SMT201700200T1 (it) 2017-05-08
MX2014006705A (es) 2014-07-09
TWI560170B (en) 2016-12-01
BR112014013541B1 (pt) 2022-02-15
CY1118785T1 (el) 2017-07-12
HK1202874A1 (en) 2015-10-09
US8841452B1 (en) 2014-09-23
AU2012347261A1 (en) 2014-06-19
CL2014001454A1 (es) 2014-10-03
JP6086925B2 (ja) 2017-03-01
RU2014126489A (ru) 2016-01-27
SG11201402956UA (en) 2014-07-30
TW201335110A (zh) 2013-09-01
SI2788357T1 (sl) 2017-06-30
DK2788357T3 (en) 2017-04-24
JO3251B1 (ar) 2018-09-16
CN104093721B (zh) 2016-05-18
IL232826A0 (en) 2014-08-03
KR20140103288A (ko) 2014-08-26
CA2857096A1 (en) 2013-06-13
RU2631652C2 (ru) 2017-09-26
ES2622156T3 (es) 2017-07-05
MX354331B (es) 2018-02-27
CA2857096C (en) 2021-01-19
HUE033717T2 (en) 2017-12-28
ME02668B (me) 2017-06-20
CN104093721A (zh) 2014-10-08
PT2788357T (pt) 2017-04-24
AU2012347261B2 (en) 2016-12-01
BR112014013541A2 (pt) 2017-06-13
EP2788357B1 (en) 2017-03-01

Similar Documents

Publication Publication Date Title
MX361183B (es) Derivados de 1,4-ciclohexilamina y procesos para la preparación de los mismos.
MX2013000793A (es) Composicion que contiene galacto-oligosacarido y un metodo para producirla.
TN2014000539A1 (en) Foam prevention in the reserve flotation process for purifying calcium carbonate
PL2545019T3 (pl) Sposób i urządzenie do destylacyjnego otrzymywania czystego 1,3-butadienu z surowego 1,3-butadienu
MX2011013112A (es) Solventes novedosos para la produccion de dispersiones de poliuretano.
WO2012015999A3 (en) Process for the preparation of imatinib mesylate
WO2013121436A3 (en) A process for preparation of rivaroxaban and intermediates thereof
MY165487A (en) Process for preparing a polyol ether
GB201210256D0 (en) Improved butanol recovery process
CY1118785T1 (el) Διαδικασια για την ανακτηση υδροχλωρικης ναλμεφενης
WO2013076743A3 (en) Process for the purification of polyaminocarboxylates
WO2010119450A3 (en) An improved process for the preparation of desmopressin or its pharmaceutically acceptable salts
WO2014141294A3 (en) An improved process for the synthesis of melphalan and the hydrochloride salt
IN2013MU04056A (enExample)
WO2013072766A3 (en) Process for cabazitaxel and intermediates thereof
IN2014DN07407A (enExample)
WO2013046233A3 (en) Process for the preparation of octreotide acetate
EA201171413A1 (ru) Способ получения олмесартана медоксомила
IN2012DN06607A (enExample)
IN2014CN00834A (enExample)
HK1202555A1 (en) Process for the manufacture of cyclic undecapeptides
IN2014CN00817A (enExample)
MX361888B (es) Un procedimiento mejorado para producir zilpaterol.
WO2011132045A3 (en) Process for the preparation of dienogest substantially free of impurities
PL392036A1 (pl) Sposób odzysku renu z amoniakalnych roztworów w postaci renianu (VII) amonu wysokiej czystości